Do dopamine agonists prevent or reduce the severity of ovarian hyperstimulation syndrome in women undergoing assisted reproduction? A systematic review and meta-analysis-Reference-Cited by-同舟云学术

Do dopamine agonists prevent or reduce the severity of ovarian hyperstimulation syndrome in women undergoing assisted reproduction? A systematic review and meta-analysis

Published:2013-09 Issue:3 Volume:16 Page:168-174
ISSN:1464-7273
Container-title:Human Fertility
language:en
Short-container-title:Human Fertility

Author:

Baumgarten Miriam,Polanski Lukasz,Campbell Bruce,Raine-Fenning Nick

Publisher

Informa UK Limited

Subject

Obstetrics and Gynaecology,Reproductive Medicine,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/14647273.2013.833348

Reference30 articles.

1. 100 CABERGOLINE VERSUS HUMAN ALBUMIN IN PROPHYLAXY OF OVARIAN HYPERSTIMULATION SYNDROME

2. Implantation is apparently unaffected by the dopamine agonist Cabergoline when administered to prevent ovarian hyperstimulation syndrome in women undergoing assisted reproduction treatment: a pilot study

3. Dopamine Agonist Cabergoline Reduces Hemoconcentration and Ascites in Hyperstimulated Women Undergoing Assisted Reproduction

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevention of Ovarian Hyperstimulation Syndrome;Ovarian Stimulation;2022-04-30

2. Ovarian hyperstimulation syndrome following the use of GnRH agonist trigger of final oocyte maturation and freeze-all strategy: A case report and review of the literature;Asian Pacific Journal of Reproduction;2022

3. Cabergoline versus calcium infusion in the prevention of ovarian hyperstimulation syndrome: a randomised controlled study;Journal of Obstetrics and Gynaecology;2021-07-16

4. Does the timing of cabergoline administration impact rates of ovarian hyperstimulation syndrome?;Obstetrics & Gynecology Science;2021-07-15

5. Dopamine agonists for preventing ovarian hyperstimulation syndrome;Cochrane Database of Systematic Reviews;2021-04-14